New Search

If you are not happy with the results below please do another search

1121 search results for:

414

Beckman Coulter and MeMed to expand access to host immune response diagnostic to distinguish between bacterial and viral infections

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, have established a strategic partnership to jointly develop and commercialize the MeMed BV test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access […]

415

Exothera appoints Darren Leva as Chief Business Officer

Exothera, a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, has appointed Darren Leva as Chief Business Officer. Darren’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets.

416

Vetter joins UN Global Compact Network for sustainability

Vetter has recently become a participant of the UN Global Compact Network (UN GC). Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. The company has longterm experience in supporting biotechnology and pharmaceutical customers both large and small. […]

417

IIVS and Toxys agree to offer ToxTracker for in vitro genetic toxicity evaluation

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker assay. ToxTracker is an innovative in vitro assay allowing identification of the genotoxic and potentially carcinogenic properties of novel and existing drugs, (agro)chemicals, cosmetics and other substances without the use of animal testing.

419

ProBioGen makes three new appointments to support growth

ProBioGen has seen significant growth with over 300 employees now working across its three locations in Berlin. In line with this growth, three crucial positions have been filled. Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team, while Dr Michiel Stork […]

420

Insight into clinical sample and consent tracking

Clinical specimens, clinical trial samples and the information associated with them are precious resources that require careful curation. CLI caught up with David Kaye [Vice President and General Manager of BioFortis (a Q2 Solutions company)] to find out more about what this entails.